Detalhe da pesquisa
1.
Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry.
J Neurol Neurosurg Psychiatry
; 95(7): 620-625, 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242680
2.
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60.
J Neurol Neurosurg Psychiatry
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453478
3.
No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.
Mult Scler
; : 13524585241240406, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511853
4.
Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late-onset Tay-Sachs disease.
J Inherit Metab Dis
; 47(2): 327-339, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112342
5.
COVID-19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark.
Eur J Neurol
; 31(3): e16163, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015454
6.
Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
Brain
; 146(6): 2316-2331, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36448302
7.
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain
; 146(11): 4633-4644, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369086
8.
Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
J Neurol Neurosurg Psychiatry
; 94(1): 23-30, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171104
9.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414534
10.
Disability accrual in primary and secondary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 707-717, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37068931
11.
Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences.
Mult Scler
; 29(11-12): 1437-1451, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840276
12.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433775
13.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
14.
Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult Scler
; 29(3): 326-332, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800908
15.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
16.
Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS).
Dysphagia
; 38(4): 1087-1095, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289072
17.
CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS.
Int J Mol Sci
; 24(12)2023 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373196
18.
The way to data: opinions and recommendations for the provision of health data for secondary use.
Cas Lek Cesk
; 162(2-3): 61-66, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474288
19.
Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!
Vnitr Lek
; 69(5): 294-298, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827827
20.
Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(12): 1330-1337, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36261289